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regarding metabolic tumor volume as well as functional lung volume 
with the intent to design the beam portal for sparing functional lung. 
Patients and Methods: Nine patients of lung cancer suitable for 
radiotherapy had CT scan, MIBI (Sestamibi) SPECT and MAA 
(Macro-Aggregated Albumin) SPECT scans with ﬁducial markers and 
accurately co-registered using statistical parametric mapping software. 
These registered images were transferred into the planning system in 
which MIBI-SPECT images guided the target volume delineation and 
MAA-SPECT scans were used to deﬁne volume of perfused ‘function-
ing’ lung. When feasible, the design of the beam portal was placed 
attempting for a conformal approach. The gross tumor volume (GTV) 
of CT and MIBI, whole lung (WL) and functional lung (FL) volumes 
were calculated. The volume of lung receiving more than 20 Gy (V20) 
and mean lung dose (MLD) for WL and FL were also calculated. 
Results: MIBI and perfusion images was co-registered with radiother-
apy planning CT scans for delineation of target and functional lung. In 
comparison to the CT deﬁned target volumes, the MIBI deﬁned target 
volume were smaller in 4, larger in 1, similar in 2 and no appreciable 
uptake in 2 patients (these patients had also received prior chemo-
therapy). Perfusion SPECT revealed the ipsilateral lung completely non 
functional (same side as tumor) in 3 patients and so the functional lung 
was spared. In the other 6 patients with perfusion defect in and around 
the tumor bearing region, an attempt was made for conformal approach 
to spare the functional lung. (1.ppt)
Conclusion: SPECT images with MIBI and MAA were useful for map-
ping the metabolic target volume and functional lung. This enables to 
design beam portals for conformal avoidance of functional lung so as to 
reduce radiation morbidity.
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A brief questionnaire was performed before starting a new prospective 
clinical trial employing concurrent radiochemotherapy (CRCT) for 
stage III non-small cell lung cancer (NSCLC) in 2005 to survey radia-
tion oncologists’ attitudes. A questionnaire consisted of 12 questions, 
which intended to evaluate career length, personal comfort degree on 
CRCT, preferred radiation dose schedules, and target volumes both in 
radiation alone and CRCT settings. This was circulated among 28 can-
didate radiation oncologists who would participate in the CRCT trial, 
and 17 responses were collected. 
Career lengths were longer than 5 years in six (35.3%), 2~5 years in 
seven (41.2%), and shorter than 2 years in four (23.5%). All respon-
dents agreed on the efﬁcacy of CRCT, however, 10 (58.8%) were not 
comfortable with CRCT regimen. There was minor tendency toward 
more conservative attitudes with respects to fractional dose, doses to 
primary, gross/elective lymph nodes, and most distal lymphatics to 
cover, mainly based on concerns of increased side effects, however, 
none was signiﬁcant. 
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Introduction: Brain metastases are three times less common in non-
small cell lung cancers (NSCLC) compared to small cell lung cancer 
(SCLC).Patients with SCLC are offered prophylactic cranial irradiation 
(PCI) as part of radical treatment in limited stage disease. PCI is not 
routinely offered in NSCLC, however as the treatments for NSCLC 
improve, especially with new targeted therapy agents in conjunction 
with chemotherapy and radiotherapy we are ﬁnding that patients are 
increasingly relapsing in the brain. Therefore the beneﬁcial role of pro-
phylactic cranial irradiation in patients with NSCLC is questioned and 
is the subject of a number of on-going trials. We present a review of our 
experience at Guys and St. Thomas’ Hospital to challenge this question.
Objective: A retrospective review of all patients with brain metastases 
from either small or non-small cell lung cancers over a period of six 
months to identify clinico-pathological markers that could categorize 
patients with NSCLC who would beneﬁt from prophylactic cranial 
irradiation. 
Methods: All patients with the diagnosis of lung cancer were identi-
ﬁed on electronic patient records, via the lung cancer nurses and the 
radiotherapy department between May and October 2006. The data was 
then collected by extraction from the case notes. The main outcome 
measures were occurrence of brain metastases and whether it was 
dependent on the initial stage of the disease.
Results: The total number of patients found was 75, out of which those 
with non small cell lung cancer were 58 (77.3%) and those with small 
cell lung cancer were 17 (22.6%). In the non small cell lung cancer 
group 8 out of the total of 58 (13.79%) developed brain metastases 
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